Skip to main content
Go to homepage

Response-Based Chemotherapy in Treating Newly Diagnosed Acute Myeloid Leukemia or Myelodysplastic Syndrome in Younger Patients With Down Syndrome

Treating Acute Myeloid Leukemia or Myelodysplastic Syndrome in Younger Patients With Down Syndrome

Description:

For complete study information, please view the study on clinicaltrials.gov.

Interested in participating?
We are currently recruiting
Full IRB Study Title:
Risk-Stratified Therapy for Acute Myeloid Leukemia in Down Syndrome
IRB Study ID:
1038450-1
Lead Investigator
Steven Kuerbitz, MD

Director, Divisional Research and Stem Cell Transplantation; Pediatric Hematologist-Oncologist
Showers Family Center for Childhood Cancer and Blood DisordersPediatric Stem Cell Transplant Program